WaveNet Pharma

Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts?

If CNBC’s Pharmaceutical Reporter focused less on misguided study or census findings and more on patient/doctor insights he would do himself and his audience a great service.

He must be in that ignorant minority who believe that those who are on Vytorin will switch out to other medications because of a botched –up panel discussion !! All the doctors I spoke with are amazed at the media coverage of an isolated and ill-conceived study whose findings, delivered as a monologue, defied all scientific conventions of an interactive panel discussion. As a patient who has tried everything over the last 25 years, I know that Zetia delivers amazing LDL lowering effects and that for patients who need a statin along with Zetia (and there are plenty apparently), nothing beats Vytorin in convenience and economics.
It is about time we start reporting facts and not survey resullts of projected intentions bordering on fiction.